Patent Opposition Database

Hide annotations

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): P000104058
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Date: 30-01-2003
Patent type: Formulations

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

10 similar patent oppositions

CILFA opposition, rosuvastatin, (P000104057)

Countries: Argentina Date: 2002
CILFA opposition, bempedoic acid, (AR114396A1)

Countries: Argentina Date: 2020
CILFA opposition, AMLODIPINE, LOSARTÁN AND ROSUVASTATINA, (AR098417A1)

Countries: Argentina Date: 2017
CILFA opposition, Ezetimibe and Rosuvastatin, (AR098996A1)

Countries: Argentina Date: 2016
CILFA opposition, metformin, simvastatin or atorvastatin,benazepril, lisinopril or losartan, aspirin, (AR091739A1)

Countries: Argentina Date: 2015
CILFA opposition, linagliptin, (AR083878A1)

Countries: Argentina Date: 2013
CILFA opposition, celecoxib, (P990106069)

Countries: Argentina Date: 2004
CILFA opposition, carvedilol+hydrochlorothiazide, (P990105974)

Countries: Argentina Date: 2002
CILFA opposition, Nadifloxacin, (P990106490)

Countries: Argentina Date: 2002
CILFA opposition, fexofenadine+cyclodextrins, (P990105185)

Countries: Argentina Date: 2002